Financials
Valore 202020212022202320242025 Current
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics
Notizie
HSBC declassa Pfizer per mancanza di catalizzatori a breve termine
Pfizer, ok FDA a Ibrance per il tumore al seno: le azioni salgono
Pfizer dichiara un dividendo trimestrale di $0,43 per il terzo trimestre
FDA approva Ibrance per il cancro al seno HR+ indipendentemente dallo stato HER2
Un dirigente di Pfizer: la Cina supera l’Europe nell’innovazione farmaceutica
BMO conferma rating Outperform su Pfizer grazie alla pipeline
Cantor Fitzgerald conferma il rating Neutral su Pfizer dopo il fallimento del trial
Perché il titolo Pfizer è in calo oggi?
Il trial di Pfizer sul tumore al polmone non raggiunge l’endpoint primario
Effetto Ozempic: come i farmaci anti-obesità cambiano la borsa
Pfizer conferma le previsioni 2026 dopo l’annuncio del cambio di CFO
Grafici & Idee
PFE - Daily Trading Forecast
Daily price was bounced from support level at 25.19 to above for 200 SMA to be crossed for the bullish trend to be resumed. Stochastic oscillator is showing the oversold market condition for the price, and Parabolic SAR is on uptrend for the price to be started so the bullish trend continuation is very likely for D1 price for example. if the price breaks 26.54 resistance level to above for the 27.85 possible target so the primary bullish trend will be resumed; If the price crosses support level at 25.19 to below so the bearish reversal will be started with 24.83 as the target to re-enter; alternatively, the price will be on secondary ranging to be near 200 SMA waiting for the direction of the strong trend to be started. Trading Summary : ranging for direction
1 The PFE doesn’t have other trading ideas at this time
Browse ready-made trading ideas or select a symbol and create your own
Go to Charts and Trading Ideas